Schedule 13D - Activist Investments
NASDAQ
GLPG
Galapagos NVEcoR1 Capital, LLC and its affiliated funds have significantly increased their beneficial ownership in Galapagos NV to 13.22% through recent open market purchases of American Depositary Shares and Ordinary Shares.
NASDAQ
GLPG
Galapagos NVSCHEDULE 13D/A: EcoR1 Capital Significantly Increases Stake in Galapagos NV to 11.84% with Over $371 Million Investment
Investment firm EcoR1 Capital, LLC and its affiliated funds have significantly increased their beneficial ownership in Galapagos NV to 11.84% of outstanding shares through recent open market purchases totaling over $371 million.
Better than expected
NASDAQ
GLPG
Galapagos NVTang Capital Management and affiliated entities have disclosed a 7.5% beneficial ownership stake in Galapagos NV, acquired for investment purposes, and may seek discussions regarding the company's operations or governance.
NASDAQ
GLPG
Galapagos NVSCHEDULE 13D/A: Galapagos NV and Gilead Announce Strategic Spin-off of Assets to Form New Biotech Entity, SpinCo
Galapagos NV and Gilead Sciences, Inc. have entered into a Separation Agreement to demerge certain assets and cash into a new entity, SpinCo, while Galapagos NV sharpens its focus on innovative cell therapies for cancer.
Capital raise
Schedule 13G - Passive Investments
NASDAQ
GLPG
Galapagos NVTang Capital Management and related entities have amended their filing for Galapagos NV, indicating a shift from an active to a passive investment stance with an 8.4% stake.